4//SEC Filing
Voermann Karsten 4
Accession 0001809519-24-000177
CIK 0001809519other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 7:59 PM ET
Size
8.3 KB
Accession
0001809519-24-000177
Insider Transaction Report
Form 4
Voermann Karsten
Chief Financial Officer
Transactions
- Tax Payment
Class A Common Stock
2024-09-08$7.71/sh−24,700$190,437→ 273,899 total - Exercise/Conversion
Class A Common Stock
2024-09-08+54,064→ 298,599 total - Exercise/Conversion
Restricted Stock Unit
2024-09-08−54,064→ 432,512 total→ Class A Common Stock (54,064 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001822140
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 7:59 PM ET
- Size
- 8.3 KB